Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 176,319 | 256,577 | 212,958 | 130,996 | 183,189 |
| Cost of Goods | 8,869 | 1,147 | 0 | N/A | N/A |
| Gross Profit | 167,450 | 255,430 | 212,958 | 130,996 | 183,189 |
| Operating Expenses | 360,199 | 344,891 | 299,651 | 248,277 | 233,231 |
| Operating Income | -191,880 | -89,314 | -86,693 | -117,281 | -50,042 |
| Interest Expense | 2,402 | 2,876 | 10,991 | 9,706 | 10,725 |
| Other Income | 5,553 | 15,548 | 11,568 | 6,433 | 2,628 |
| Pre-tax Income | -188,729 | -76,642 | -86,116 | -120,554 | -58,139 |
| Income Tax | 360 | 328 | 304 | 321 | -71 |
| Net Income Continuous | -189,291 | -76,970 | -86,420 | -120,875 | -58,068 |
| Net Income | $-189,291 | $-76,970 | $-86,420 | $-120,875 | $-58,068 |
| EPS Basic Total Ops | -52.75 | -22.25 | -25.75 | -41.50 | -23.25 |
| EPS Basic Continuous Ops | -52.67 | -22.21 | -25.70 | -41.40 | -23.14 |
| EPS Diluted Total Ops | -52.75 | -22.25 | -25.75 | -41.50 | -23.25 |
| EPS Diluted Continuous Ops | -52.67 | -22.21 | -25.70 | -41.40 | -23.14 |
| EPS Diluted Before Non-Recurring Items | -52.75 | -22.25 | N/A | N/A | N/A |
| EBITDA(a) | $-169,730 | $-71,527 | $-80,173 | $-109,338 | $-41,273 |